Shinya Yamada

Dr. Shinya Yamada

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Circulation Journal
Verified
Journal Article
Open access
PDF file
SYShinya Yamada
Shinya Yamada
HSHitoshi Suzuki
Hitoshi Suzuki
MKMasashi Kamioka
Masashi Kamioka
SSSatoshi Suzuki
Satoshi Suzuki
YKYoshiyuki Kamiyama
Yoshiyuki Kamiyama
YTYasuchika Takeishi
Yasuchika Takeishi
Background: It has been shown that sleep-disordered breathing (SDB) is associated with adverse prognosis in patients with chronic heart failure (CHF), but little is known about the relationship between SDB and life-threatening arrhythmias. Methods and Results: Fifty patients with CHF and SDB (33 male; mean age, 61 years) underwent Holter electrocardiogram and portable sleep monitoring simultaneously. The circadian variation in positive T-wave alternans (TWA; >65μV) was determined during 6-h intervals (0–6, 6–12, 12–18, and 18–24h). In addition, power spectral analysis of heart rate variability (HRV) was evaluated across a 24-h period. The subjects were divided into 2 groups based on whether respiratory disturbance index was ≥20events/h (Group A, n=24) or not (Group B, n=26). The prevalence of positive TWA, parameters in HRV and the occurrence of ventricular tachycardia (>5 beats) were compared between the 2 groups. The prevalence of positive TWA in Group A was significantly higher than that in Group B in all 6-h intervals. Low-frequency and high-frequency powers of HRV were significantly lower in Group A than in Group B across a 24-h period. Importantly, the prevalence of ventricular tachycardia was significantly higher in Group A than in Group B (46% vs. 19%, P=0.04). Conclusions: SDB may induce cardiac electrical instability associated with life-threatening arrhythmias across a 24-h period in CHF. (Circ J 2013; 77: 1466–1473)

21 February 2020 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
PDF file
SYShinya Yamada
Shinya Yamada
AYAkiomi Yoshihisa
Akiomi Yoshihisa
NHNaoko Hijioka
Naoko Hijioka
MKMasashi Kamioka
Masashi Kamioka
TKTakashi Kaneshiro
Takashi Kaneshiro
YTYasuchika Takeishi
Yasuchika Takeishi
Background: Cardiac amyloidosis (CA) is characterized by left ventricular hypertrophy (LVH) and autonomic nervous imbalance due to amyloid infiltration. However, autonomic dysfunction is often seen in heart failure (HF) with LVH from other etiologies. We aimed to characterize autonomic dysfunction in CA from other etiologies of LVH.Methods: Fifty‐five HF patients with LVH (35 males, mean age 65 ± 16 years) were enrolled. LVH was defined as left ventricular mass index measured by echocardiography >95 g/m2 in women and 115 g/m2 in men. The etiology was as follows: amyloid light chain (AL)‐CA, n = 14; hypertrophic cardiomyopathy, n = 21; and aortic stenosis (AS), n = 20. With the patient in a clinically stable condition, heart rate variability (HRV) and heart rate turbulence (HRT), which reflect autonomic dysfunction, were measured using Holter monitoring and compared among the three groups.Results: Brain natriuretic peptide levels, LVH severity, left ventricular ejection fraction, and tissue Doppler index E/e′ did not differ among the three groups. However, severe abnormalities of HRV and HRT were obtained in AL‐CA. In the ROC analysis to identify AL‐CA in HF with LVH, the best cutoff value for standard deviation of all R‐R intervals, standard deviation of the 5‐min mean R‐R intervals, turbulence onset, and turbulence slope were 68.5 ms (AUC: 0.865), 58.5 ms (AUC: 0.834), 0.25% (AUC: 0.813), and 1.00 ms/RR (AUC 0.736), respectively.Conclusion: Autonomic dysfunction is a hallmark of AL‐CA, and its noninvasive assessment by Holter monitoring may be a useful tool for differential diagnosis of HF with LVH.

18 May 2018 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
SYShinya Yamada
Shinya Yamada
AYAkiomi Yoshihisa
Akiomi Yoshihisa
YSYu Sato
Yu Sato
TSTakamasa Sato
Takamasa Sato
MKMasashi Kamioka
Masashi Kamioka
YTYasuchika Takeishi
Yasuchika Takeishi

18 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SYShinya Yamada
Shinya Yamada
TKTakashi Kaneshiro
Takashi Kaneshiro
AYAKIOMI YOSHIHISA
AKIOMI YOSHIHISA
MNMinoru Nodera
Minoru Nodera
KAKazuaki Amami
Kazuaki Amami
YTYasuchika Takeishi
Yasuchika Takeishi
Background: Liver function may be a useful indicator of response to cardiac resynchronization therapy (CRT). We aimed to investigate the clinical significance of albumin-bilirubin (ALBI) score, an assessment tool of liver function, on outcomes in heart failure (HF) patients treated with CRT. Methods: We studied 180 patients undergoing CRT. The ALBI score, derived from albumin and total bilirubin, and left ventricular ejection fraction (LVEF) were assessed before and 6 months after CRT. The patients were classified according to the ALBI score before CRT; High (>−2.60) or Low (≤−2.60) ALBI groups. The patients were then reclassified based on the ALBI score before and 6 months after CRT; High/High, High/Low, Low/High, and Low/Low ALBI groups. We evaluated the prognostic value of the ALBI score for HF deaths after CRT. Results: During a median follow-up period of 50 months, there were 41 (22.7%) HF deaths. A Cox proportional hazard analysis revealed that high ALBI scores at baseline were not related to HF deaths (hazard ratio, 1.907, p = 0.068). However, High/High ALBI scores, but not High/Low or Low/High ALBI scores, were an independent predictor of HF deaths compared with Low/Low ALBI scores (hazard ratio, 3.449, p = 0.008), implying that consistently high ALBI scores were associated with poor prognosis. The percentage change in LVEF from baseline to 6 months after CRT did not differ among the four groups, suggesting that left ventricular systolic function was not linked with the ALBI score. Conclusions: ALBI scores before and after CRT are a new indicator of CRT response, and have a predictive value for HF deaths in HF patients.

1 January 2012 in FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
Verified
Journal Article
Open access
PDF file
SYShinya Yamada
Shinya Yamada
HSHitoshi Suzuki
Hitoshi Suzuki
MKMasashi Kamioka
Masashi Kamioka
YKYoshiyuki Kamiyama
Yoshiyuki Kamiyama
SSShu-Ichi Saitoh
Shu-Ichi Saitoh
YTYasuchika Takeishi
Yasuchika Takeishi
Backgrounds. Elevated uric acid (UA) level is reported to be related to the development of left ventricular hypertrophy (LVH) which is associated with high incidence of ventricular tachycardia (VT) and sudden cardiac death. However, little is known about the association between serum UA levels and the occurrence of VT. Thus, we examined the relationship between serum UA levels and the appearance of VT in patients with LVH. Methods. The study subjects consisted of 167 patients (110 males, mean age 67.4 ± 12.7 years) with LVH detected by echocardiography. These patients were divided into two groups based on whether VT was presented (defined by more than 5 beats, n=27) or not (n=140) by 24-hour Holter ECG monitoring. Left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVDd), the E/A ratio and deceleration time of transmitral flow velocity were assessed by echocardiography in each group. In addition, blood urea nitrogen (BUN), creatinine, estimated glomerular filtration rate (eGFR), sodium, potassium, hemoglobin, total bilirubin and UA were compared in each group. Results. Echocardiographic findings did not show the difference between the two groups. However, BUN and UA levels in the VT group were significantly higher than those in the Non-VT group (p< 0.01). eGFR was significantly lower in the VT group than that in the Non-VT group (p< 0.01). A multivariate logistic regression analysis identified the UA level as an independent predictive factor for the occurrence of VT (odds ratio 1.61, 95% confidence interval 1.1-2.2, p< 0.01). Conclusions. These results suggest that serum UA level is a useful marker for predicting ventricular arrhythmias in patients with LVH.

12 September 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
THTing‐Chun Huang
Ting‐Chun Huang
LLLi-Wei Lo
Li-Wei Lo
SYShinya Yamada
Shinya Yamada
YCYu‐Hui Chou
Yu‐Hui Chou
WLWei‐Lun Lin
Wei‐Lun Lin
SCShih‐Ann Chen
Shih‐Ann Chen